Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans
- PMID: 17969210
- DOI: 10.1002/lt.21262
Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans
Abstract
Organ allocation for liver transplantation (LT) in the United States is based on the Model for End-Stage Liver Disease (MELD) score. The MELD score prioritizes organ distribution to sicker patients. There is limited data on the effect of this policy on transplantation in the Veterans Affairs (VA) healthcare system. The aim of this study was to determine the impact of the MELD score on U.S. veteran patients undergoing LT. Comparison of MELD scores and waiting time of LT recipients before and after the introduction of the MELD system was done. A total of 192 LT recipients were analyzed. Blood type, diagnosis, listing MELD score, and Child-Turcotte-Pugh (CTP) score at transplant did not differ although MELD era recipients were older (mean 54.3 vs. 51.3 yr, P = 0.009). Mean waiting time decreased from 461 days (pre-MELD) to 252 days (MELD era) (P = 0.004). Mean MELD score at LT increased from 23.4 (MELD era) compared to 20.3 (pre-MELD) (P = 0.01). In conclusion, waiting time for LT in U.S. veterans has decreased significantly in the MELD era. The MELD score of patients transplanted in the MELD era is significantly higher and patients are still being listed at a high MELD score. The MELD system has lead to sicker veterans being transplanted with shorter waiting times.
(c) 2007 AASLD.
Similar articles
-
Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072. Transplant Proc. 2008. PMID: 18675085
-
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016. Transplant Proc. 2008. PMID: 18675084
-
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.Liver Transpl. 2007 Jun;13(6):857-66. doi: 10.1002/lt.21155. Liver Transpl. 2007. PMID: 17539006
-
Patient selection criteria for liver transplantation.Minerva Chir. 2003 Oct;58(5):635-48. Minerva Chir. 2003. PMID: 14603144 Review.
-
Liver transplantation in the era of model for end-stage liver disease.Liver Int. 2004 Feb;24(1):1-8. doi: 10.1111/j.1478-3231.2004.00888.x. Liver Int. 2004. PMID: 15101994 Review.
Cited by
-
¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis.World J Gastroenterol. 2012 Jan 21;18(3):285-90. doi: 10.3748/wjg.v18.i3.285. World J Gastroenterol. 2012. PMID: 22294833 Free PMC article.
-
Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis.BMJ Open Gastroenterol. 2019 Nov 26;6(1):e000342. doi: 10.1136/bmjgast-2019-000342. eCollection 2019. BMJ Open Gastroenterol. 2019. PMID: 31875140 Free PMC article.
-
Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil.Clinics (Sao Paulo). 2011;66(1):57-64. doi: 10.1590/s1807-59322011000100011. Clinics (Sao Paulo). 2011. PMID: 21437437 Free PMC article.
-
Principles and reality of proton therapy treatment allocation.Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):499-508. doi: 10.1016/j.ijrobp.2014.03.023. Epub 2014 May 3. Int J Radiat Oncol Biol Phys. 2014. PMID: 24798985 Free PMC article.
-
Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.Gastroenterol Hepatol Bed Bench. 2020 Winter;13(Suppl1):S113-S121. Gastroenterol Hepatol Bed Bench. 2020. PMID: 33585012 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical